搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
2minutemedicine.com
15 分钟
Caregivers of people with dementia may benefit from online decision aid when managing ...
In this randomized controlled trial involving caregivers for people with Alzheimer’s disease and related dementias, the use ...
2minutemedicine.com
3 小时
Sex differences in mortality among patients with lupus nephritis
Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.
2minutemedicine.com
14 小时
Sanofi’s Sarclisa approved as first-line for transplant-ineligible multiple myeloma patients
Sarclisa in combination with the VRd regiment was superior to VRd alone in improving survival in stem cell transplant ...
2minutemedicine.com
1 天
Computer-aided detection may improve detection of polyps and adenomas compared with ...
In this updated systematic review and meta-analysis, computer-aided detection found more polyps and adenomas per colonoscopy ...
2minutemedicine.com
4 天
Mineralocorticoid receptor antagonists reduce hospitalizations in patients with heart ...
Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients compared to HFmrEF and HFpEF ...
2minutemedicine.com
5 天
Tag: hepatology
ALG-055009, a thyroid hormone receptor agonist, significantly reduced liver fat in patients with MASH after 12 weeks of treatment. ALG-055009 ...
2minutemedicine.com
5 天
Aligos Therapeutics: ALG-055009 reduces liver fatty deposits in patients with metabolic ...
ALG-055009, a thyroid hormone receptor agonist, significantly reduced liver fat in patients with MASH after 12 weeks of treatment. ALG-055009 was well tolerated, with no serious adverse events The ...
2minutemedicine.com
5 天
Perioperative pembrolizumab improves survival in resectable early-stage non-small cell lung ...
Grade 3-5 adverse events were comparable between both treatment groups. Evidence Rating Level: 1 (Excellent) Study Rundown: ...
2minutemedicine.com
6 天
Tag: chemotherapy
1. 36-month overall survival and median event-free survival were significantly greater in the pembrolizumab group compared to control. 2. Grade ...
2minutemedicine.com
6 天
Tag: immunotherapy
1. 36-month overall survival and median event-free survival were significantly greater in the pembrolizumab group compared to control. 2. Grade ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈